Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
CANCER:
T Acute Lymphoblastic Leukemia
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related cancers:
‹
Leukemia (2150
)
Acute Myelogenous Leukemia (1007
)
Acute Lymphocytic Leukemia (418
)
Chronic Lymphocytic Leukemia (326
)
Chronic Myeloid Leukemia (267
)
B Acute Lymphoblastic Leukemia (193
)
Childhood B Acute Lymphoblastic Leukemia (37
)
Hairy Cell Leukemia (23
)
Chronic Myelomonocytic Leukemia (20
)
Prolymphocytic Leukemia (17
)
Acute Promyelocytic Leukemia (12
)
Juvenile Myelomonocytic Leukemia (5
)
Chronic Eosinophilic Leukemia (4
)
Chronic Neutrophilic Leukemia (3
)
Leukemia (2150
)
Acute Myelogenous Leukemia (1007
)
Acute Lymphocytic Leukemia (418
)
Chronic Lymphocytic Leukemia (326
)
Chronic Myeloid Leukemia (267
)
B Acute Lymphoblastic Leukemia (193
)
Childhood B Acute Lymphoblastic Leukemia (37
)
Hairy Cell Leukemia (23
)
Chronic Myelomonocytic Leukemia (20
)
Prolymphocytic Leukemia (17
)
Acute Promyelocytic Leukemia (12
)
Juvenile Myelomonocytic Leukemia (5
)
Chronic Eosinophilic Leukemia (4
)
Chronic Neutrophilic Leukemia (3
)
›
Associations
(39)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
T Acute Lymphoblastic Leukemia
No biomarker
T Acute Lymphoblastic Leukemia
nelarabine
Sensitive: A1 - Approval
nelarabine
Sensitive
:
A1
nelarabine
Sensitive: A1 - Approval
nelarabine
Sensitive
:
A1
No biomarker
T Acute Lymphoblastic Leukemia
No biomarker
T Acute Lymphoblastic Leukemia
cyclophosphamide + etoposide oral + nelarabine
Sensitive: A2 - Guideline
cyclophosphamide + etoposide oral + nelarabine
Sensitive
:
A2
cyclophosphamide + etoposide oral + nelarabine
Sensitive: A2 - Guideline
cyclophosphamide + etoposide oral + nelarabine
Sensitive
:
A2
No biomarker
T Acute Lymphoblastic Leukemia
No biomarker
T Acute Lymphoblastic Leukemia
vincristine + prednisone + daunorubicin + pegaspargase + nelarabine
Sensitive: A2 - Guideline
vincristine + prednisone + daunorubicin + pegaspargase + nelarabine
Sensitive
:
A2
vincristine + prednisone + daunorubicin + pegaspargase + nelarabine
Sensitive: A2 - Guideline
vincristine + prednisone + daunorubicin + pegaspargase + nelarabine
Sensitive
:
A2
TP53 mutation
T Acute Lymphoblastic Leukemia
TP53 mutation
T Acute Lymphoblastic Leukemia
venetoclax
Sensitive: C1 - Off-label
venetoclax
Sensitive
:
C1
venetoclax
Sensitive: C1 - Off-label
venetoclax
Sensitive
:
C1
NOTCH1 mutation
T Acute Lymphoblastic Leukemia
NOTCH1 mutation
T Acute Lymphoblastic Leukemia
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
FBXW7 mutation
T Acute Lymphoblastic Leukemia
FBXW7 mutation
T Acute Lymphoblastic Leukemia
prednisone
Resistant: C3 – Early Trials
prednisone
Resistant
:
C3
prednisone
Resistant: C3 – Early Trials
prednisone
Resistant
:
C3
HGF-L
T Acute Lymphoblastic Leukemia
HGF-L
T Acute Lymphoblastic Leukemia
mogamulizumab-kpkc
Resistant: C3 – Early Trials
mogamulizumab-kpkc
Resistant
:
C3
mogamulizumab-kpkc
Resistant: C3 – Early Trials
mogamulizumab-kpkc
Resistant
:
C3
NOTCH1 L1574Q
T Acute Lymphoblastic Leukemia
NOTCH1 L1574Q
T Acute Lymphoblastic Leukemia
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
NOTCH1 V1577E
T Acute Lymphoblastic Leukemia
NOTCH1 V1577E
T Acute Lymphoblastic Leukemia
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
NOTCH1 L1600Q
T Acute Lymphoblastic Leukemia
NOTCH1 L1600Q
T Acute Lymphoblastic Leukemia
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
NOTCH1 L1585R
T Acute Lymphoblastic Leukemia
NOTCH1 L1585R
T Acute Lymphoblastic Leukemia
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
NOTCH1 V1577A
T Acute Lymphoblastic Leukemia
NOTCH1 V1577A
T Acute Lymphoblastic Leukemia
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.